• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Gilead Sciences

Gilead Sciences

Gilead Sciences Inc GILD

Last Price$88.21Day Change (%)-9.06%
Open Price$91.19Day Change ($)-8.79
Day Range87.80–92.5352-Week Range81.89–123.37

As of Fri 4/29/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. European CHMP Adopts Positive Opinion for Gilead ’s TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for Treatment of HIV

    European CHMP Adopts Positive Opinion for Gilead ’s TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for Treatment of HIV

  2. European Commission Grants Marketing Authorization for Gilead ’s Fixed-Dose Combination Descovy® (Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV

    European Commission Grants Marketing Authorization for Gilead ’s Fixed-Dose Combination Descovy® (Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV

  3. Gilead Announces Full 48-Week Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection

    Gilead Announces Full 48-Week Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection

  4. Gilead Announces Multiple Scientific Presentations Demonstrating Broad Utility of Sofosbuvir-Based Hepatitis C Therapies

    Gilead Announces Multiple Scientific Presentations Demonstrating Broad Utility of Sofosbuvir-Based Hepatitis C Therapies

  5. Gilead Presents New Data Highlighting Progress in Liver Fibrosis

    Gilead Presents New Data Highlighting Progress in Liver Fibrosis

  6. UPDATE: Are overextended corporate board members costing investors money?

    UPDATE: Are overextended corporate board members costing investors money?

  7. New York Insurers to Change Coverage of Hepatitis C Drugs

    New York Insurers to Change Coverage of Hepatitis C Drugs

  8. UPDATE: This is the most expensive drug in America

    UPDATE: This is the most expensive drug in America

  9. UPDATE: Broadening sector participation -2-

    UPDATE: Broadening sector participation -2-

  10. UPDATE: Broadening sector participation signals bull trend has room to run

    UPDATE: Broadening sector participation signals bull trend has room to run

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.